Accelerating research today to reinvent the health care of tomorrow
In 2023, the Servier Research and Development Institute will open its doors in the Paris-Saclay interdisciplinary innovation cluster. In a few years, this scientific center of excellence will bring together nearly 25% of French scientific research. What is Servier’s objective? To develop R&D that is more agile, more open and increasingly patient-centric, in order to accelerate the discovery of innovative therapeutic solutions.
The ambition of the Servier R&D institute in Paris-Saclay is clear. It’s to bring the Group’s power to innovate together with a very high potential ecosystem. By choosing Paris-Saclay, Servier is also committed to local economic development and supports the attractiveness of French research.
sq. m building
Up to 1,500 employee capacity
1,850 sq. m start-up incubator with 110-person capacity
Now at the heart of one of the world’s most dynamic innovation ecosystems, Servier is seizing a unique opportunity to create new partnerships and increase synergies with institutional and private research players. Servier’s teams will work in a very high-level ecosystem.
The Group already has relationships with many local players, such as the French National Center for Scientific Research (CNRS), the French Alternative Energies and Atomic Energy Commission (CEA), the University of Paris-Saclay and École Polytechnique. Servier is also involved in organizing events such as SPRING Saclay, TEDxSaclay, and the Paris-Saclay University Symposium.
the Paris-Saclay Cluster, a unique hub for research
Ranked among the eight leading clusters for innovation worldwide, along with Silicon Valley, Beijing, Boston and Silicon Wadi in Israel, Paris-Saclay has top-tier international influence. The site is home to key names in research as well as international companies, start-ups, and renowned universities such as Paris-Saclay University — the first French university included in the prestigious Shanghai ranking.
Paris-Saclay represents 15% of French research by number of researchers and 40% of employment in public and private research in the Greater Paris region. In time, it will represent 25% of French research.
The start-up incubator at the Servier Research and Development Institute is the sole initiative of its kind in France. This new synergy between the momentum of new, future-facing companies and Servier’s pharmaceutical knowledge will therefore create unique conditions that will showcase and accelerate therapeutic research.
Spanning 1,850 sq. m, the incubator will house various types of workstations — featuring laboratories with state-of-the-art equipment alongside offices specially designed to facilitate discussion, as well as reception and food service area.
BioLabs, a world-renowned American incubator operator, will oversee day-to-day management at the facility, supply equipment, provide services, offer practical support, and organize events and programs specially designed for start-ups operating in the life sciences industry.
The incubator has been designed to accommodate up to 110 people, i.e., about 15 start-ups, which will change every two years on average.
True to its corporate social responsibility policy (CSR), the Group has decided to make the Servier Research and Development Institute in Paris-Saclay a truly exemplary facility. The Group is aiming for the BiodiverCity® label, coupled with WELL Building Standard™ and HQE™ quality certifications, thanks to an eco-friendly building that respects biodiversity.
The international BiodiverCity® label certifies a level of excellence in ecological and sustainable construction.
The WELL Building Standard™ certification focuses on the health and well-being of occupants.
The High Environmental Quality™ (HQE) certification recognizes buildings that offer the best environmental and energy performance, right from their design.
5,000 sq. m of grounds
9,000 sq. m of green roofs
100 sq. m of community gardens
Over 70 plant species